The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Abstract
OBJECTIVE: The authors review the mechanisms and establish the risk of torsade de pointes and sudden death with antipsychotic drugs. METHOD: They present a review of original concepts, the distinction between familial and drug-induced cases of torsade de pointes, and the recognition of the role of noncardiac drugs in torsade de pointes and sudden death. They review the evidence linking QTc interval prolongation, potassium channels, and torsade de pointes from both the long QT syndrome and drugs. They examine the risk for torsade de pointes from antipsychotic drugs and estimate the frequency of sudden death on the basis of epidemiological data in normal and schizophrenic populations. RESULTS: All drugs that cause torsade de pointes prolong the QTc interval and bind to the potassium rectifier channel, but the relationships are not precise. Prediction of torsade de pointes and sudden death can be improved by examining dose dependency, the percent of QTc intervals higher than 500 msec, and the risk of drug-drug interactions. Although sudden unexpected death occurs almost twice as often in populations treated with antipsychotics as in normal populations, there are still only 10-15 such events in 10,000 person-years of observation. CONCLUSIONS: Although pimozide, sertindole, droperidol, and haloperidol have been documented to cause torsade de pointes and sudden death, the most marked risk is with thioridazine. There is no association with olanzapine, quetiapine, or risperidone. Ziprasidone does prolong the QT interval, but there is no evidence to suggest that this leads to torsade de pointes or sudden death. Only widespread use will prove if ziprasidone is entirely safe. To date, all antipsychotic drugs have the potential for serious adverse events. Balancing these risks with the positive effects of treatment poses a challenge for psychiatry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study
Henderson, D. C., Cagliero, E., Gray, C., Nasrallah, R. A., Hayden, D. L., Schoenfeld, D. A., & Goff, D. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.975 · Cited by 701
Torsades de Pointes Occurring in Association With Terfenadine Use
Monahan, B. P. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450210088038 · Cited by 667
Mechanism of the Cardiotoxic Actions of Terfenadine
Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646
Predicting Sudden Death in the Population: The Paris Prospective Study I
Jouven, X., Desnos, M., Guerot, C., & Ducimetière, P. (1999) · Circulation · doi:10.1161/01.cir.99.15.1978 · Cited by 644
Novel antipsychotics: comparison of weight gain liabilities.
Wirshing, D. A., Wirshing, W. C., Kysar, L., Berisford, M. A., Goldstein, D., Pashdag, J., Mintz, J., & Marder, S. R. (1999) · PubMed · Cited by 523
Nicotine Dependence in Schizophrenia: Clinical Phenomena and Laboratory Findings
Dalack, G. W., Healy, D. J., & Meador-Woodruff, J. H. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1490 · Cited by 498
Measurement of the QT interval and the risk associated with QTc interval prolongation: A review
Moss, A. J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90036-c · Cited by 472
Antipsychotics and the Risk of Sudden Cardiac Death
Ray, W. A., Meredith, S., Thapa, P. B., Meador, K. G., Hall, K., & Murray, K. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1161 · Cited by 429
[Ventricular tachycardia with 2 variable opposing foci].
Dessertenne, F. (1966) · PubMed · Cited by 414
Novel antipsychotics and new onset diabetes
Wirshing, D. A., Spellberg, B. J., Erhart, S. M., Marder, S. R., & Wirshing, W. C. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00100-0 · Cited by 407
Novel Antipsychotics: Comparison of Weight Gain Liabilities
Wirshing, D. A., Wirshing, W. C., Kysar, L., Berisford, M. A., Goldstein, D., Pashdag, J., Mintz, J., & Marder, S. R. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0602 · Cited by 393
George, T. P., Ziedonis, D. M., Feingold, A., Pepper, W. T., Satterburg, C. A., Winkel, J., Rounsaville, B. J., & Kosten, T. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1835 · Cited by 354
Kelly, C., & McCreadie, R. G. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1751 · Cited by 317
Prolonged QT interval predicts cardiac and all-cause mortality in the elderly The Rotterdam Study
de Bruyne, M. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1276 · Cited by 298
Cardiovascular Effects of Therapeutic Doses of Tricyclic Antidepressants: A Review
Glassman, A. H. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780320095011 · Cited by 269
Self-citationElectrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs
Fowler, N. O., McCall, D., Chou, T.-C., Holmes, J. C., & Hanenson, I. B. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90316-7 · Cited by 248
The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered
Glassman, A. H. (1993) · JAMA · doi:10.1001/jama.269.20.2673 · Cited by 245
Self-citationQT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
De Ponti, F., Poluzzi, E., & Montanaro, N. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050714 · Cited by 240
Cardiovascular Adverse Effects of Antipsychotic Drugs
Buckley, N. A., & Sanders, P. (2000) · Drug Safety · doi:10.2165/00002018-200023030-00004 · Cited by 235
Torsades de Pointes Associated With Intravenous Haloperidol in Critically Ill Patients
Sharma, N. D., Rosman, H. S., Padhi, I. D., & Tisdale, J. E. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00888-6 · Cited by 232
Olanzapine Increases Weight and Serum Triglyceride Levels
Osser, D. N., Najarian, D. M., & Dufresne, R. L. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1109 · Cited by 229
Moderate Alcohol Consumption and the Risk of Sudden Cardiac Death Among US Male Physicians
Albert, C. M., Manson, J. E., Cook, N. R., Ajani, U. A., Gaziano, J. M., & Hennekens, C. H. (1999) · Circulation · doi:10.1161/01.cir.100.9.944 · Cited by 208
Mehtonen, O. ‐., Aranko, K., Mälkonen, L., & Vapaatalo, H. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb01421.x · Cited by 187
(1963) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1963.03710030141099 · Cited by 187
Familial And Acquired Long QT Syndrome And The Cardiac Rapid Delayed Rectifier Potassium Current
Witchel, H. J., & Hancox, J. C. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03337.x · Cited by 170
Novel Antipsychotics and Severe Hyperlipidemia
Meyer, J. M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00003 · Cited by 168
Tricyclic Antidepressants in Depressed Patients With Cardiac Conduction Disease
Roose, S. P. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800150093011 · Cited by 157
Risk of torsades de pointes with non-cardiac drugs
Yap, Y. G. (2000) · BMJ · doi:10.1136/bmj.320.7243.1158 · Cited by 155
The QT Interval and Torsade de Pointes
Moss, A. J. (1999) · Drug Safety · doi:10.2165/00002018-199921001-00002 · Cited by 154
Electrocardiographic changes in patients receiving neuroleptic medication
Warner, J. P., Barnes, T. R. E., & Henry, J. A. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10653.x · Cited by 133
The Association Between Intravenous Haloperidol and Torsades de Pointes
Hunt, N., & Stern, T. A. (1995) · Psychosomatics · doi:10.1016/s0033-3182(95)71609-7 · Cited by 120
Clozapine-Associated Elevation in Serum Triglycerides
Gaulin, B. D., Markowitz, J. S., Caley, C. F., Nesbitt, L. A., & Dufresne, R. L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1270 · Cited by 119
Antipsychotic agents and QT changes.
Welch, R. W., & Chue, P. S. (2000) · PubMed Central · Cited by 115
Second-generation antihistamines: The risk of ventricular arrhythmias
DuBuske, L. M. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88286-7 · Cited by 105
Olanzapine-Induced Glucose Dysregulation
Bettinger, T. L., Mendelson, S. C., Dorson, P. G., & Crismon, M. L. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19327 · Cited by 105
Roden, D. M. (1993) · Clinical Cardiology · doi:10.1002/clc.4960160910 · Cited by 102
Case Study: Two Additional Sudden Deaths With Tricyclic Antidepressants
Varley, C. K., & McClellan, J. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199703000-00018 · Cited by 90
Ketoacidosis as a side‐effect of clozapine: a case report
Kostakolu, A. E., Yazici, M. K., Erbas, T. A., & Guvener, N. D. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10635.x · Cited by 78
Daniel, D. G., Wozniak, P., Mack, R. J., & McCarthy, B. G. (1998) · PubMed · Cited by 74
Flockhart, D. A., Drici, M., Kerbusch, T., Soukhova, N. V., Richard, E., Pearle, P. L., Mahal, S. K., & Babb, V. J. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200006000-00005 · Cited by 73
Life-Threatening Ventricular Arrhythmia (Torsades de Pointes) after Haloperidol Overdose
Henderson, R. A., Lane, S. M., & Henry, J. A. (1991) · Human & Experimental Toxicology · doi:10.1177/096032719101000110 · Cited by 72
Sudden Death in Patients Receiving Clozapine Treatment: A Preliminary Investigation
Modai, I., Hirschmann, S., Rava, A., Kurs, R., Barak, P., Lichtenberg, P., & Ritsner, M. S. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200006000-00006 · Cited by 59
Lewis, R. A., Bagnall, A., & Leitner, M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001715.pub2 · Cited by 55
Kobayashi, T., Ikeda, K., & Kumanishi, T. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703224 · Cited by 55
Safety concerns over antipsychotic drug, sertindole
Barnett, A. A. (1996) · The Lancet · doi:10.1016/s0140-6736(05)65549-3 · Cited by 34
Cardiovascular side effects of phenothiazines and tricyclic antidepressants
Lipscomb, P. A. (1980) · Postgraduate Medicine · doi:10.1080/00325481.1980.11715402 · Cited by 32
Roberts, D. J. (1999) · Drug Safety · doi:10.2165/00002018-199921001-00011 · Cited by 5
Cited by
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Myerburg, R. J., Quinones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,973
REDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.178233 · Cited by 1,080
Physical Health Monitoring of Patients With Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., Kane, J. M., Lieberman, J. A., Schooler, N. R., Covell, N., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1334 · Cited by 812
Self-citation
Metadata
- Authors
- Glassman, A. H., & Bigger, J. T.
- Venue
- American Journal of Psychiatry
- Published
- 2001-11-01
- Volume
- 158
- Issue
- 11
- Pages
- 1774-1782
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2162857263
- Cited by
- 822
- References
- 48
- FWCI
- 33.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.